🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/08/2000 44,34 45,19 43,13 45,00 +2,56% 4,65% 30.500
03/08/2000 42,38 45,00 42,19 43,88 +1,74% 6,64% 26.100
02/08/2000 43,13 43,88 42,00 43,13 +1,77% 4,35% 22.000
01/08/2000 42,75 43,50 41,63 42,38 +1,80% 4,39% 22.967
31/07/2000 39,56 43,50 39,19 41,63 +8,29% 10,90% 58.200
28/07/2000 41,25 41,81 37,50 38,44 -5,96% 10,45% 64.983
27/07/2000 42,19 43,88 40,88 40,88 -9,17% 7,11% 207.717
26/07/2000 45,38 47,63 44,25 45,00 +0,00% 7,44% 39.333
25/07/2000 46,50 47,81 44,63 45,00 -6,98% 6,85% 16.000
24/07/2000 50,25 50,81 48,00 48,38 -2,27% 5,60% 16.767
21/07/2000 49,78 51,00 48,00 49,50 +2,33% 6,03% 15.833
20/07/2000 48,75 49,50 48,38 48,38 -0,77% 2,31% 14.150
19/07/2000 50,06 51,00 48,75 48,75 -0,76% 4,49% 6.917
18/07/2000 50,25 50,25 49,13 49,13 -1,50% 2,24% 30.100
17/07/2000 50,63 51,00 48,00 49,88 +1,92% 5,93% 33.150
14/07/2000 52,50 52,50 47,63 48,94 -4,04% 9,29% 38.667
13/07/2000 54,00 55,13 51,00 51,00 -5,56% 7,64% 13.317
12/07/2000 55,50 55,50 53,63 54,00 -1,37% 3,38% 13.833
11/07/2000 56,63 57,00 54,00 54,75 -2,67% 5,30% 16.150
10/07/2000 57,00 57,38 54,75 56,25 -1,32% 4,61% 8.483
07/07/2000 56,63 58,13 55,50 57,00 +0,00% 4,64% 6.400
06/07/2000 57,38 58,50 55,50 57,00 +0,00% 5,23% 6.783
05/07/2000 58,13 60,00 56,25 57,00 -3,18% 6,45% 11.633
03/07/2000 60,00 60,75 57,00 58,88 -0,63% 6,25% 7.867
30/06/2000 61,88 61,88 58,50 59,25 -2,47% 5,45% 7.100
29/06/2000 60,19 61,13 58,50 60,75 +0,00% 4,36% 19.233
28/06/2000 56,25 61,13 55,88 60,75 +10,96% 9,33% 20.833
27/06/2000 57,38 59,25 54,75 54,75 -3,95% 7,84% 13.533
26/06/2000 58,50 60,00 57,00 57,00 -2,56% 5,13% 9.483
23/06/2000 60,75 61,13 57,75 58,50 -2,50% 5,56% 13.300